Novo Nordisk NVO announced that it has submitted a regulatory application to the European Medicines Agency (EMA) seeking ...

Syndax now has two approved therapies, but the share price remains under pressure despite these milestones. See why SNDX ...

The GOP tax bill repeals the Inflation Reduction Act’s price controls for drugs for rare diseases.

While their functions are diverse, myosins are similar in structure. NMII is so much like cardiac myosin, which keeps the ...

Boston Scientific announced the FDA approval of expanded labeling for its pulsed field ablation system which now includes ...

Adcentrx Therapeutics ("Adcentrx"), a clinical-stage biotechnology company redefining Antibody-Drug Conjugate (ADC) therapies for cancer treatment and other life-threatening diseases, today announced ...

Merck & Co., Inc. is acquiring Verona Pharma plc for $10bn to bolster long-term growth with COPD drug Ohtuvayre. Click for my ...

The country’s Medicines and Healthcare products Regulatory Agency’s Yellow Card scheme, the UK’s official system for ...

"Imcranib 100", the first targeted cancer drug in tablet form developed and produced in Thailand, is the result of the ...

When surgeons dissect tissue to remove a tumor or make a repair, they must work cautiously, relying on electrophysical ...

Novartis' blockbuster immunology drug Cosentyx has disappointed in a phase 3 trial involving patients with giant cell ...

Alexander Malyshev and Sarah Ganley of Carter Ledyard & Milburn LLP discuss a gray area when the 2018 Farm Bill legalized ...